GT Biopharma (GTBP) Gains (Losses) on Sale of Assets & Investments (2019 - 2024)
GT Biopharma (GTBP) recorded Gains (Losses) on Sale of Assets & Investments of $2,000 in Q3 2024, down 60.0% from $5,000 a year earlier but up 100.0% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Gains (Losses) on Sale of Assets & Investments (2019 - 2024) Analysis & Trends
On a TTM basis, GT Biopharma's Gains (Losses) on Sale of Assets & Investments came in at $6,000 as of Sep 30, 2024, down 90.9% year-over-year; for FY2023, it came in at $48,000.
- Annual Gains (Losses) on Sale of Assets & Investments has a four-year compound annual growth rate of -78.0% (FY2019 to FY2023).
- Across earlier years, Gains (Losses) on Sale of Assets & Investments came in at -$30,000 in FY2022, -$29,000 in FY2021 and $20.46 million in FY2019.
- Quarterly Gains (Losses) on Sale of Assets & Investments has ranged from -$33,000 in Q3 2021 to $40.96 million in Q4 2019 over the past five years.
- On a year-over-year basis, Gains (Losses) on Sale of Assets & Investments rose in 1 of the last four quarters, with growth averaging 62.0%.
- Per Business Quant, the preceding three quarters came in at $1,000 (Q2 2024), -$2,000 (Q1 2024) and $5,000 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 29,000.00 |
| Dec 31, 2022 | 23,000.00 |
| Sep 30, 2022 | -23,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Mar 31, 2022 | -24,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | -33,000.00 |
| Dec 31, 2019 | 40.96 Mn |
| Sep 30, 2019 | -20.46 Mn |
| Jun 30, 2019 | -31,000.00 |
API Access
GT Biopharma Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();